Fangzhou Inc.

HK$1.00As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6086Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 2Y CAGR (48.65%)
Div yield —
ROE 3.70%
Pharmaceutical Retailers
Beta (5Y) 0.42
PE TTM 142.8
TSR TTM (71.85%)
Mkt cap HK$1.392B
ROIC 2.04%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.16
15.31%
(58.70%)
Buy 5|11|6|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
18.04%
19.93%
11.91%
19.89%
Revenue¥M
87.05
91.23
92.28
92.22
15.40%
18.19%
14.34%
9.79%
Peers (US$177.6M)
Cap (US$)
PE
293.4M
10.87x
288.3M
15.78x
162.4M
—
Capital
TTM
5Y
10Y
Leveragex
6.454
(0.037)
(0.038)
EBIT/Intx
4.281
0.443
0.328
Own earn%
(26.12)
78.74
82.11
Sh yield%
38.27
19.26
19.00
Owners
Insiders/Inst%
7.12
55.84
Short interest%
3.51
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
12–15
$1 testx
—
Incr. ROIC%
36